Walleye Trading
BLPH

Walleye Trading’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Walleye Trading’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-47
Closed -$1K – 5693
2016
Q2 		$1K Hold
47
– – ﹤0.01% 5215
2016
Q1 		$2K Buy
+47
New +$1.74K ﹤0.01% 5151

Other funds holding BLPH

NMVA
New Mountain Vantage Advisers New York $4.33B AUM 35.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GA
Geneva Advisors Chicago, Illinois $5.81B AUM 23.71% 1-Year Est. Return

Walleye Trading's BLPH Position: Q3 2016 in Review

Walleye Trading sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q3 2016, closing a stake of 47 shares — an estimated $1K sold.

Walleye Trading first reported a position in BLPH in Q1 2016 and held it in 2 quarters. The position peaked at $2K in Q1 2016. 15 funds tracked by Wall St. Rank hold BLPH as of Q3 2016.

  • Walleye Trading reported no remaining Bellerophon Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Walleye Trading sold 47 Bellerophon Therapeutics, Inc. shares in Q3 2016, an estimated $1K.
  • Walleye Trading first reported a position in Bellerophon Therapeutics, Inc. in Q1 2016 and held it in 2 quarters.
  • Walleye Trading's Bellerophon Therapeutics, Inc. position peaked at $2K in Q1 2016.
  • 15 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.